Search Grant Opportunities

Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)

ID: RFA-OD-27-009 • Type: Posted
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Sign in to upload a capability statement or catalogue for your company

Analyze Opportunity
Generate a Draft
Loading

Description

Posted:
This Notice of Funding Opportunity (NOFO) announces the renewal of the NIH Research Evaluation and Commercialization Hub (REACH) program, established to facilitate and accelerate the translation of academic biomedical discoveries into products that improve patient care and public health. Through this program, NIH will provide the qualifying institutions with the funds to seed the creation of academic entrepreneurship Hubs. Hubs will be responsible for providing innovators with both the initial investment and resources to support the proof-of-concept work and the mentorship in product development and commercialization needed to develop high priority technologies within the NIH's mission. Funded Hubs are intended to work as a consortium to enable: (1) the infrastructure for identifying the most promising technologies, (2) funding for product definition studies (e.g. feasibility studies, prototype development, proof-of-concept studies) provided to individual researchers, (3) access to resources and expertise in areas required for early stage technology development (including scientific, regulatory, reimbursement, business, legal, and project management), and (4) skills development and hands-on experience in entrepreneurship. Establishing public-private partnerships and providing additional non-federal funds will be critical for success. This is a Notice of Funding Opportunity (NOFO) for a Limited Competition that will invite applications from eligible organizations to apply. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding.
Posted:
Posted:
Posted:
Posted:
Posted:
Background
The NIH Research Evaluation and Commercialization Hub (REACH) program aims to facilitate and accelerate the translation of academic biomedical discoveries into products that enhance patient care and public health. Funded by the National Institutes of Health (NIH), this program supports the creation of academic entrepreneurship Hubs that provide innovators with initial investments, resources for proof-of-concept work, and mentorship in product development and commercialization. The goal is to develop high-priority technologies aligned with NIH's mission.

Grant Details
The REACH program will fund qualifying institutions to create Hubs responsible for:

1) Establishing infrastructure for identifying promising technologies;

2) Providing funding for product definition studies such as feasibility studies, prototype development, and proof-of-concept studies;

3) Offering access to resources and expertise necessary for early-stage technology development, including scientific, regulatory, reimbursement, business, legal, and project management support;

4) Facilitating skills development and hands-on experience in entrepreneurship.

Each Hub is expected to select and fund at least five Technology Development Projects annually, which may include feasibility studies, validation, prototype development, and proof-of-concept studies. The maximum budget for a Hub is $1 million total costs per year over a maximum project period of four years.

Eligibility Requirements
Eligible applicants include higher education institutions (public/state controlled or private), nonprofits (with or without 501(c)(3) status), and other research institutions that have participated in the NIH STTR program as formal partners. Preference will be given to applications from primary applicant organizations located in IDeA-eligible states. Foreign organizations are not eligible to apply.

Period of Performance
The maximum project period is four years.

Grant Value
The total funding available is estimated at $20 million to fund up to five awards at $5 million per year.

Place of Performance
Preference is given to IDeA-eligible states.

Overview

Category of Funding
Health
Funding Instruments
Grant
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 9/24/26 the National Institutes of Health posted grant opportunity RFA-OD-27-009 for Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional) with funding of $5.0 million. The grant will be issued under grant program 93.310 Trans-NIH Research Support. It is expected that 5 total grants will be made.

Timing

Posted Date
Closing Date
Due in 26 Days
Last Updated
Version
1
Archive Date

Eligibility

Eligible Applicants
Public and State controlled institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Additional Info
The primary applicant organization must be a university or other research institution that participates in the NIH STTR program. Participation means that a university or other research institution has been a formal partner to a small business on an STTR award.

Award Sizing

Ceiling
Not Listed
Floor
Not Listed
Estimated Program Funding
$5,000,000
Estimated Number of Grants
5

Contacts

Contact
National Institutes of Health
Contact Email
Contact Phone
(301) 402-2541

Documents

Posted documents for RFA-OD-27-009

Opportunity Assistant


Analyze Opportunity

Generate a Draft

Potential Applicants and Partners

Awardees that have recently won grants similar to RFA-OD-27-009

Incumbent or Similar Grants

Grants similar to RFA-OD-27-009

Similar Active Opportunities

Open grant opportunities similar to RFA-OD-27-009

Experts for Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)

Recommended subject matter experts available for hire